Large Cap Biopharmaceuticals Performance Update 2018: Part 2

go to site buy cheap Maxalt without prescription Large Cap Biopharmaceuticals: Winners and Losers, Takeaways

Here is a brief analysis from data below. Data Sources : Google Finance and FinViz.com.

  1. Our Top Picks continue to do well: Abbvie (ABBV), Bristol-Myers Squibb (BMY) and Gilead Sciences (GILD).
  2. Laggards in our focus group are Biogen (BIIB) and Celgene (CELG).Both lack drivers and revenue or EPS growth.
  3. The biotech sector is in a strong bull market outperforming the NASDAQ and the S&P 500 however many analysts do not have a “strong buy” ( under 2.0) on large caps given the strong run over 12 months and YTD.
  4. The Fidelity Select Biotechnology Portfolio (FBIOX) continues to outperform the IBB but the FBT is the new ETF leader barely edging out the XBI over 12 mos. Both are off all time highs reached in late January and momentum has eased.
  5. Investors picked up a selective laggard quickly this month: Alexion (ALXN) but Celgene (CELG) and Regeneron (REGN) are longer term laggards.

The Rayno Biopharmaceutical Portfolio will not be re-balanced at this time and all positions remain a hold. Aggressive investors should focus on small and mid-cap biotech stocks or the XBI as they all benefit from M&A news. We bought Seattle Genetics (SGEN) last week at a price of ~$52.

Disclosure: Long ABBV, BMY, CELG, FBIOX, GILD, SGEN,XBI

 

http://aspenlogandbeetlekillpinefurniture.com/project_category/bookcases-and-credenzas/ Large Cap. Biopharmaceuticals 2/19/18

Company Ticker Price 2017 Market P/S PEG Q/Q Q/Q % Perf P % Perf DIV ARec
1/7/2016 Rev$B Cap $B REV EPS 12 mos 2/19/18 YTD *
2/19/2018 Gr% Gr% 2/19
Abbvie ABBV 57.21 27.27 189.4 6.94 1.58 8.8 4.4 92 118.6 22.6 2.84 2.4
Alexion ALXN 174.37 3.25 27.2 7.66 2.87 9.6 -66.5 -6.48 120.47 0.74 1.8
Amgen AMGN 158 22.85 133.3 5.83 16.29 -0.7 2.9 5.9 183.55 5.55 2.88 2.4
Biogen BIIB 284.01 12.27 63.3 5.16 3.83 15.1 -147 1 291.87 -8.38 2
Bristol Myers BMY 65.27 20.78 112.9 5.43 8.87 6.7 -28.2 26.3 68.96 12.53 2.32 2.3
Celgene CELG 111.89 13 72.3 5.56 1.3 16.9 -119.6 -21.4 95.26 -8.72 2.2
Gilead Sci GILD 96.25 26.11 106.5 4.08 -13.2 -17.1 15.5 80.7 12.65 2.83 2.2
Merck MRK 40.12 153.5 3.83 10.52 -2.2 -102.6 -13.9 56.29 0 3.41 2.1
Regeneron REGN 501.96 5.87 35.8 6.1 2.87 29 -31.3 -10.5 332.15 -11.65 2.4
Vertex VRTX 2.43 40.7 16.3 1.1 39.7 -159.4 81.9 160.72 7.25 1.8
IBB 304 8.18 12.47 110.36 3.36 316.33
XBI 61.82 2.75 33.15 92.47 8.95
FBIOX 9.3 19 237.6 9.56
FBT 35.4 138.44 11.1
*Recom
No comments yet.

Leave a Reply